Natural statins and stroke risk

被引：100

作者：

Furberg, CD ^{[1
]}

机构：

[1] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA

来源：

CIRCULATION | 1999年 / 99卷 / 02期

关键词：

editorials; statins; stroke;

D O I：

10.1161/01.CIR.99.2.185

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：185 / 188

页数：4

共 23 条

[1]

[Anonymous], 1995 HEART STROK FAC

[2] Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia [J].

BakkerArkema, RG ;

Davidson, MH ;

Goldstein, RJ ;

Davignon, J ;

Isaacsohn, JL ;

Weiss, SR ;

Keilson, LM ;

Brown, WV ;

Miller, VT ;

Shurzinske, LJ ;

Black, DM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02) :128-133

[3] Infarctlike lesions in the brain: Prevalence and anatomic characteristics at MR imaging of the elderly - Data from the cardiovascular health study [J].

Bryan, RN ;

Wells, SW ;

Miller, TJ ;

Elster, AD ;

Jungreis, CA ;

Poirier, VC ;

Lind, BK ;

Manolio, TA .

RADIOLOGY, 1997, 202 (01) :47-54

[4] REDUCTION IN CARDIOVASCULAR EVENTS DURING PRAVASTATIN THERAPY - POOLED ANALYSIS OF CLINICAL EVENTS OF THE PRAVASTATIN ATHEROSCLEROSIS INTERVENTION PROGRAM [J].

BYINGTON, RP ;

JUKEMA, JW ;

SALONEN, JT ;

PITT, B ;

BRUSCHKE, AV ;

HOEN, H ;

FURBERG, CD ;

MANCINI, J .

CIRCULATION, 1995, 92 (09) :2419-2425

[5] HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data [J].

Crouse, JR ;

Byington, RP ;

Furberg, CD .

ATHEROSCLEROSIS, 1998, 138 (01) :11-24

[6] Surrogate end points in clinical trials: Are we being misled? [J].

Fleming, TR ;

DeMets, DL .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :605-613

[7] EFFECT OF LOVASTATIN ON EARLY CAROTID ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS [J].

FURBERG, CD ;

ADAMS, HP ;

APPLEGATE, WB ;

BYINGTON, RP ;

ESPELAND, MA ;

HARTWELL, T ;

HUNNINGHAKE, DB ;

LEFKOWITZ, DS ;

PROBSTFIELD, J ;

RILEY, WA ;

YOUNG, B .

CIRCULATION, 1994, 90 (04) :1679-1687

[8]

Gould AL, 1998, CIRCULATION, V97, P946

[9] AN OVERVIEW OF TRIALS OF CHOLESTEROL-LOWERING AND RISK OF STROKE [J].

HEBERT, PR ;

GAZIANO, JM ;

HENNEKENS, CH .

ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (01) :50-55

[10] SERUM-CHOLESTEROL LEVELS AND 6-YEAR MORTALITY FROM STROKE IN 350,977 MEN SCREENED FOR THE MULTIPLE RISK FACTOR INTERVENTION TRIAL [J].

ISO, H ;

JACOBS, DR ;

WENTWORTH, D ;

NEATON, JD ;

COHEN, JD .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (14) :904-910

← 1 2 3 →